Entity > Corporation > US > New York City New York > Gilead Sciences
About Gilead Sciences
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Gilead Sciences
| Company Attribute | Value |
| Name | Gilead Sciences |
| Url | gilead |
| Wikipedia | wikipedia |
| Wikidata | wikidata |
Gilead Sciences
New York City, US
16 May 2024
Gilead Sciences
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.gilead.com/
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Rich Sitelinks
People Also Ask
https://en.wikipedia.org › wiki › Gilead_Sciences
Gilead Sciences, Inc is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral ...
https://twitter.com/GileadSciences?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Twitter Boxes
https://www.linkedin.com/company/gilead-sciences
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in ...
https://finance.yahoo.com › quote › GILD
Apr 23, 2024 — Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in ...
https://www.forbes.com › companies › gilead-sciences
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet.
https://www.gileadclinicaltrials.com/
Explore Gilead clinical trials for breast cancer, HIV prevention, and more. See how Gilead clinical trials help support our vision of a healthier world.
Knowledge Panel
Gilead Sciences (Pharmaceutics company)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
-
Stock price : GILD (NASDAQ) $67.01 -0.64 (-0.95%)May 15, 4:00 PM EDT - Disclaimer
-
CEO : Daniel O'Day (Mar 1, 2019–)
-
Headquarters : Foster City, CA
-
Revenue : 24.69 billion USD (2020)
-
Subsidiaries : Kite Pharma, Cymabay Therapeutics, Inc., MORE
-
CFO : Andrew Dickinson
-
Founder : Michael L. Riordan
-
Founded : June 22, 1987, Foster City, CA
| Entity Home | Kalicube Pro Entity Page |
| Gilead Sciences Entity Home | Gilead Sciences on Kalicube |
| Amgen Entity Home | Amgen on Kalicube |
| Bristol Myers Squibb Entity Home | Bristol Myers Squibb on Kalicube |
| Genentech Entity Home | Genentech on Kalicube |
| Gilead Sciences Entity Home | Gilead Sciences on Kalicube |
| Genentech Entity Home | Genentech on Kalicube |
| Sanofi Entity Home | Sanofi on Kalicube |